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Abstract
Duchenne and Becker muscular dystrophy patients often develop a cardiomyopathy for which the pathogenesis is still
unknown. We have employed the murine animal model of Duchenne muscular dystrophy (mdx), which develops a
cardiomyopathy that includes some characteristics of the human disease, to study the molecular basis of this pathology.
Here we show that the mdx mouse heart has defects consistent with alteration in compounds that regulate energy
homeostasis including a marked decrease in creatine-phosphate (PC). In addition, the mdx heart is more susceptible to
anoxia than controls. Since the cardio-protective ATP sensitive potassium channel (KATP) complex and PC have been shown
to interact we investigated whether deficits in PC levels correlate with other molecular events including KATP ion channel
complex presence, its functionality and interaction with dystrophin. We found that this channel complex is present in the
dystrophic cardiac cell membrane but its ability to sense a drop in the intracellular ATP concentration and consequently
open is compromised by the absence of dystrophin. We further demonstrate that the creatine kinase muscle isoform (CKm)
is displaced from the plasma membrane of the mdx cardiac cells. Considering that CKm is a determinant of KATP channel
complex function we hypothesize that dystrophin acts as a scaffolding protein organizing the KATP channel complex and the
enzymes necessary for its correct functioning. Therefore, the lack of proper functioning of the cardio-protective KATP system
in the mdx cardiomyocytes may be part of the mechanism contributing to development of cardiac disease in dystrophic
patients.
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Introduction
Cardiomyopathy is frequently associated with Duchenne and
Becker muscular dystrophy. Indeed, with the increased lifespan of
the patients bearing such pathologies, cardiac failure is becoming
one of the most frequent causes of death [1]. The murine model of
Duchenne muscular dystrophy (mdx mutant mouse) bears a point
mutation in the gene coding for dystrophin, which causes the
premature termination of the polypeptide chain during translation
[2,3]. Consequently, mdx mice lack full-length dystrophin and
develop a late onset and progressive cardiomyopathy that has
some similarity with that observed in human dystrophic patients
[4,5]. Histological signs of disease in mouse hearts become
detectable at 6 months of age with small necrotic and infiltrative
foci. Fibrosis develops at later stages, usually by 9 months of age
[6]. The biochemical and physiological alterations observed in
young and old mdx mice have led to a number of hypotheses to
explain the pathogenesis of the cardiomyopathy. These include,
altered energetics [7], perturbation in Ca
++ handling [8], nitric
oxide (NO) signaling alterations [9,10] and increased ROS-
mediated damage [11]. Nevertheless, to date there is no evidence
of a direct link between dystrophin and any of the aforementioned
alterations in the heart.
It should also be noted that physical stress affects the cardiac
and skeletal muscles differently in the mdx-related pathogenesis.
For example, the heart is a muscle that works continuously, and
yet the cardiac disease develops relatively late as compared to the
skeletal muscle. Instead, skeletal muscles such as the diaphragm,
which are in continuous work, are more affected than other
muscles [12]. Nevertheless, even the cardiopathy of the mdx mice,
to a certain degree, has been found to worsen with increased
workload [13]. These observations suggest that dystrophin may
have different roles in skeletal and cardiac muscle. However, it is
unclear whether the lack of dystrophin has a primary role in the
myopathy by rendering the dystrophic cardiomyocytes more
fragile or by affecting the myocyte energetics, which is more
relevant when the work-load is increased. We tried to address
these questions by studying the energetics of the mdx heart in
normal and hypoxic conditions. We found consistent alterations in
energy compounds in the mdx heart, including a marked decrease
in creatine-phosphate (PC) level under normal oxygenated
conditions that become more severe under hypoxic conditions.
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ischemic insult. In searching for clues causing the decrease in PC
and increased susceptibility to ischemia we investigated the status
of the ATP sensitive potassium channel (KATP) complex since it
relies on PC for its correct functioning [14] and it is involved in
protection during ischemia [15,16]. In the heart, there are two
main KATP channel isoforms, Kir6.1 and 6.2. In addition, there
are a number of accessory subunits sensitive to sulphonilurea
(SUR), the most highly expressed being the SUR2A subunit. It has
been shown that the function of the KATP channel complex,
including the Kir6.2 and SUR2A subunit is modulated by
intracellular ATP levels. In addition, enzymes such as the creatine
kinase muscle isoform (CKm) [14] as well as other glycolytic
enzymes [17,18,19] are involved in the accurate sensing of
intracellular ATP. Specifically, it appears that the close proximity
of CKm to the Kir channel complex allows for potent modulation
of the channel activity by the CKm substrates PC and creatine,
which, respectively causes the channel to close or open.
It has been reported that activation of KATP is protective against
the effect of ischemia [16]. Furthermore, the preconditioning
activation of KATP is responsible for protecting the heart from
more severe ischemic insult [15]. Kir6.2 knockout mice bear mild
cardiac defects [20] that resemble in part the cardiomyopathy of
the mdx mice, being both progressive and late onset; furthermore
their heart, like in the mdx mice, is more susceptible to increased
workload [21,22]. These data provided the basis for our
investigation into a possible relationship between dystrophin and
the Kir6.2 and SUR2A KATP complex and to studying the KATP
complex activity in the mdx cardiomyocytes. We found a physical
interaction of the KATP channel and CKm with dystrophin, and
compromised ATP sensing capabilities by KATP channels. We
hypothesize that the altered function of the KATP system may be
responsible for the enhanced susceptibility of the mdx heart to
increased workload and ischemia.
Results
Energy compound levels in the mdx heart are severely
affected during hypoxia
It has been reported that mdx mutant hearts have metabolic
and signaling alterations preceding the development of the
cardiomyopathy. These alterations include compromised cardiac
contractile function and efficiency, reduced cellular integrity, and
exacerbated alterations in mitochondrial citric acid cycle-related
parameters and in nutrient signaling pathways related to Akt [7].
Therefore, we decided to further this analysis by testing how mdx
hearts respond to stress conditions. To investigate whether energy
compound levels in mdx hearts are more affected than in controls
during hypoxic conditions we first performed
31P NMR in
Langendorff-perfused hearts. Both wt and mdx hearts quickly
recovered spontaneous beating after the cannulation. In order to
obtain homogeneous data,
31P NMR spectra recording was
initiated 30 minutes after removal of the heart. Data collected at
this time point were considered values in normoxic conditions
since we used an oxygenated solution for the perfusion. Data
collection requires about 10 minutes per sweep and at least 4
complete sweeps were recorded in order to have a sufficient signal
to noise ratio. Although this time frame is too long to apply any
protocol to induce ischemia or hypoxia that can be reversed
without causing any permanent damage,
31P NMR spectra-
derived quantification of energy compounds is valuable because it
provides ex vivo data and it permits a valuable comparison with
the data obtained with a different technique. A series of 4 sweeps
were averaged to obtain spectra that were then used to quantify
the concentration of PC and Pi.
31P NMR spectra of wt and mdx
mouse hearts show PC/Pi ratio as well as pH values that are
significantly altered in mdx mice compared to those of wt (the ratio
is 1.1160.31 in mdx hearts versus 2.0460.16 p,0.05; in wt; the
pH value was 7.0360.03 versus 7.1960.03 p,0.02 n=5 in each
experimental group). Representative traces are shown in Fig. S1.
Since
31P NMR spectra analysis is not feasible in conjunction
with a protocol to induce ischemia we then tested energy
compound levels by HPLC on quickly frozen specimens of
Langendorff-perfused hearts under normoxic and hypoxic condi-
tions. In normoxic conditions, we confirmed the data obtained by
NMR regarding the relative levels of Pi and PC. Specifically, we
found a significantly lower PC level in mdx hearts compared to wt
(wt =36.1462.13 mmol/g dry weight; mdx =26.3161.48 mmol/
g dry weight; p,0.05) whereas the Pi was increased (wt =
10.6660.11 mmol/g dry weight; mdx =14.8361.2 mmol/g dry
weight; p,0.01; Table 1). Interestingly, under hypoxic conditions,
both wt and mdx hearts showed a comparable fall of ATP while
ADP, AMP and PC changed differently. Hypoxia caused ADP
and AMP concentrations to increase more than two-and four-fold
respectively in wt mice. However, in mdx mice, ADP did not
increase much while AMP concentration increased seven-fold,
which represents a 100% increase when compared to wt (Table 1).
Moreover, during hypoxia the PC concentration in wt hearts was
reduced to 15% of its value in normoxic condition while in the
mdx hearts its concentration was only 9.5% of its normoxic level.
These data suggest that the dystrophic hearts are more susceptible
to hypoxic insult than wt.
Loss of function of KATP in mdx hearts
It has been reported that KATP functions as an innate
mechanism of protection during cardiac adaptation to stress and
workload [18]. Therefore we investigated the functional status of
the KATP system in cardiomyocytes isolated from the mdx hearts.
We chose to analyze embryonic mdx cardiomyocytes first since we
reasoned that adult mdx cardiomyocytes might already be
compromised by an advanced dystrophic cardiomyopathy.
Opening of KATP channels caused by a reduction in the
intracellular ATP concentration generates potassium currents that
can be studied to directly investigate the functional status of KATP
channels. Therefore, we used three different approaches to reduce
Table 1. Data obtained by HPLC analysis of control and mdx
mouse hearts.
Wt mdx
Normoxic Hypoxic Normoxic Hypoxic
PC 36.1462.13 5.660.87 26.3161.48* 2.4560.61$
Cr 30.806 0.84 64.7066.04 31.0062.13 56.0062.08
Pi 10.6660.11 31.8763.49 14.8361.20* 33.1062.33
ATP 18.2560.93 8.5560.32 15.8360.89 5.8560.67
ADP 5.8060.17 12.5360.58 6.1160.24 9.1060.57$
AMP 1.2460.16 5.2861.07 1.2260.16 8.4560.32$
Normoxic and hypoxic condition are compared. The values represent the
compound concentration expressed as mmol/g dry weight 6 SE; n=5 per
group.
*t-test p,0.05 significantly different values between mdx and wt in normoxic
conditions.
$ p,0.05 by 2 way ANOVA, animal type x condition.
doi:10.1371/journal.pone.0027034.t001
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opening.
1) Dialysis of intracellular ATP. We patched the
cardiomyocytes to obtain a whole cell configuration using an
intracellular solution with no ATP. In wt cardiomyocytes we
detected a strong current within 3 to 5 minutes from the
membrane break-in (Fig. 1A). This time course is compatible
with the dialysis of the physiological intracellular ATP [23,24].
The current obtained reached its maximum within 10 minutes
after the break-in and was completely abolished by 25 mM of the
KATP specific channel blocker Glibenclamide. Furthermore,
current leakage at the holding potential of –70 mV inverted its
polarity from an inward to an outward current, indicating that the
permeability to potassium increased to an extent that the
unclamped resting potential of the cell moved closer to the
Nernst equilibrium for potassium (i.e. to the potential where
potassium is not flowing through the membrane). These data allow
the characterization of this current as a KATP mediated current
(IATP). Surprisingly, in mdx cardiomyocytes we were unable to
record any IATP (Fig. 1B).
2) Poisoning of mitochondria. We used the perforated
patch clamp method to maintain the physiological intracellular
milieu during the recording [25]. Subsequently, we reduced the
intracellular ATP level by poisoning the mitochondria with
100 mM dinitrophenol (DNP).
In wt cardiomyocytes the DNP treatment induces the
appearance of a strong potassium current that can be completely
abolished by Glibenclamide (25 mM) treatment or washout
(Fig. 2A). The DNP-induced current reaches a peak within 5
minutes from its onset. However, DNP treatment of dystrophic
cardiomyocytes does not cause any IATP current (Fig. 2A). Instead,
40–50 minutes after the DNP application the cell membrane
becomes very unstable and the seal is lost. Occasionally, some cells
are able to withstand the DNP treatment for up to one hour but
even these cells do not show any KATP mediated current,
eventually become progressively swollen and form membrane
blebs.
3) Treatment with the agonist cromakalim. Surprisingly,
a strong KATP mediated current is induced both in the perforated
and in the whole cell configuration in mdx cardiomyocytes upon
treatment with the potassium channel agonist cromakalim
(100 mM) (Fig. 2B, Fig. S2). This current was not different from
the one recorded in the wt cells either in its amplitude or in the
developing time course. The current obtained was also completely
blocked by the antagonist Glibenclamide (25 mM) as in wt cells.
The current density in all configurations was quantified at
+40 mV and normalized according to cell size (Fig. 3).
Since the agonist cromakalim acts on the KATP channel
auxiliary subunit, these data strongly suggest that the KATP
channels are present and are correctly assembled at the membrane
of the mdx cardiomyocyte. However, the cells are unable to sense
the changes in intracellular [ATP].
To investigate whether the defects observed in embryonic
cardiomyocytes were also present in the adult we analyzed the
KATP function in cardiomyocytes freshly isolated from young or
Figure 1. IATP obtained by dialysis of intracellular ATP is
missing in the mdx cardiac cells. Time course of IATP development
in wt (A) and mdx cultured cardiomyocytes (B). In wt cells the dialysis of
ATP rapidly induces the IATP current that is selectively abolished by the
application of the antagonist. In the mdx cells no IATP is induced by the
whole-cell recording conditions after 13 minutes. The current develops
rapidly after the application of the selective agonist Cromakalim and is
rapidly abolished by the selective antagonist Glibenclamide. Insets
show the current traces relative to the time point.
doi:10.1371/journal.pone.0027034.g001
Figure 2. IATP obtained by poisoning mitochondria is missing in the mdx cardiac cells. A) Time course of IATP development in wt and mdx
cultured cardiomyocytes recorded in perforated patch clamp. In wt cells treatment with DNP poisons the mitochondria, and consequently decreases
the [ATP]i leading to the disappearance of the IATP current by wash out. In the mdx cells no IATP is induced by DNP treatment after 50 minutes. Longer
treatment usually results in membrane instability and cell death. B) In mdx cardiomyocytes in perforated patch clamp the IATP current develops
rapidly after the application of the selective agonist Cromakalim, while the application of the selective antagonist Glibenclamide completely
abolishes the current. The lower trace represents the applied voltage protocol.
doi:10.1371/journal.pone.0027034.g002
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respond to DNP. Cardiomyocytes from old mdx animals also
failed to respond to DNP. Total KATP currents obtained upon
perfusion with cromakalim (100 mM) were not significantly
different between the old and young cardiomyocytes although
we noticed a tendency toward smaller values in the old mdx
cardiomyocytes (Table S2). These data suggest that the defect in
KATP function is present at every developmental stage of the mdx
cardiomyocytes and is independent of the onset of the histological
signs of cardiomyopathy.
Expression of KATP isoforms is not altered in mdx
cardiomyocytes
To gain insight into the mechanism causing the KATP channel
loss of sensitivity to intracellular ATP level in the mdx
cardiomyocytes we investigated the expression level of the different
channel isoforms. We performed RT-PCR expression analysis for
the principal (Kir6.1, Kir6.2) and the associated subunit (SUR1,
SUR2A and SUR2B) isoforms of the KATP channel in both mdx
and wt hearts. We found no changes in the level of expression of
any KATP channel isoform between the wt and dystrophic hearts
(Fig. S4). Interestingly, in the ventricular wall of the mouse heart
the mRNA for the accessory subunits SUR1, SUR2A and SUR2B
are expressed at equal levels while, as previously reported [15], the
Kir6.2 subunit is expressed at a higher level than the Kir6.1
subunit (Fig. S4). These data suggest that since there are no
imbalances in the level of expression of the different KATP channel
isoforms and subunits, other mechanisms may be causing the
KATP channel loss of sensitivity to intracellular ATP level in the
mdx cardiomyocytes.
Kir6.2 co-immunolocalizes with dystrophin
Since our electrophysiology data suggest that the KATP channels
are present and functioning in the mdx mutant cardiomyocytes we
sought to determine their subcellular localization in isolated
control and mutant cardiomyocytes. Immuno-staining of wt
cardiomyocytes showed that Kir6.2 localizes in horizontal stripes
coinciding with t-tubules, as previously reported [26] (Figure 5).
Importantly, Kir6.2 staining of mdx cardiomyocytes revealed a
similar striated t-tubule associated pattern. Optical density profiles
along the longitudinal axis of the fiber further confirmed the
overlapping staining of Kir6.2 with dystrophin in the wt
cardiomyocytes. Immunostaining with an anti-dystrophin anti-
body also showed its presence at the plasma membrane and on the
t-tubule as reported by Stevenson et al. and Frank et al. [27,28].
As expected, dystrophin was not detected in mdx mutant
cardiomyocytes. Taken together these data strongly suggest that
in wt cardiomyocytes dystrophin and Kir6.2 share the t-tubule
localization and in mdx cardiomyocytes Kir6.2 staining is still
localized at the t-tubules.
KATP and Creatine Kinase co-immuno precipitate with
dystrophin
It has been reported that dystrophinmay have scaffolding activity
since it mediates the correct membrane localization of several
different proteins in specific tissues (reviewed in [29]). Therefore, we
investigated whether it may also interact with the KATP channel
complex. We first looked for a physical interaction between
dystrophin and Kir6.2, the most highly expressed isoform of the
KATP complex. Cell lysates from mdx and wt cardiomyocytes were
immunoprecipitated with an antibody recognizing full-length
dystrophin and blotted with an antibody specific for Kir6.2. While
the Kir6.2 subunit is present in the cell lysate of both wt and mdx
hearts, its presence was detected only in the immunoprecipitation
experiment from the wt heart (Fig. 6A, Fig S3).
It has been reported that CKm physically associates with KATP
[14] therefore we tested whether CKm could also interact directly
or indirectly with dystrophin. Ventricular cell lysates were
immuno-precipitated with an anti-dystrophin antibody and the
blots were probed with an antibody specific to CKm. Again, as
observed for the Kir6.2 subunit CKm was present in the whole cell
lysates of both wt and mdx hearts but we detected the presence of
CKm only in the IP from the wild type animals (Fig. 6B). The
reverse IP was also performed to test whether dystrophin is
required for CKm interaction with Kir6.2. Cell lysates from wt
and mdx hearts were immunoprecipitated with a specific antibody
against Kir6.2 or SUR2A and analyzed for the presence of CKm
and Dys427. We found that CKm was immunoprecipitated only
in wt lysate (Fig. 7). Importantly, full length dystrophin was also
co-IP by Kir6.2 or SUR2A in wt cardiomyocytes. Since the IP was
performed in tissues and not in an artificial overexpression system,
this result strongly suggests that Kir6.2 and SUR2A do interact
directly, or as part of a protein complex with CKm in vivo and
that dystrophin is required for these interactions.
CKm membrane localization is disrupted by lack of
dystrophin
We have found that CKm is normally present in mdx
cardiomyocyte lysates (Fig. 6B) but does not interact directly in
vivo with Kir6.2 and SUR2A (Fig. 7). So we investigated whether
the loss of dystrophin would affect not only CKm interaction with
Kir6.2 and SUR2A but also its subcellular localization. Crude
lysates of ventricular wall muscle were separated into the cytosolic
and membrane fraction. The fractions were tested by western blot
for the presence of CKm, BK, and full length dystrophin (Dys427).
The BK potassium channel was used as control for the membrane
fraction. As expected, CKm was highly expressed in the cytosolic
fraction of ventricular cardiomyocytes from both wt and mdx
animals. Surprisingly, while we could detect some CKm in the
membrane fraction from wt hearts, no CKm was present in the
equivalent fraction from the mdx mice (Fig. 8). These data,
together with the co-immunoprecipitation results suggest that
dystrophin is essential for the proper localization of CKm at the
plasma membrane.
Discussion
In the present study, we tested the functionality of an
enzymatic/ion channel multimeric complex, i.e. the KATP channel
Figure 3. Summary of IATP density measured at +40 mV.
Induction of the IATP currents by: dialysis of intracellular ATP (n=8);
mitochondria poisoning with DNP (n=12); or application of the
selective agonist Cromakalim (n=9). Only in the latter case do mdx
cardiomyocytes show an IATP density similar to wt. IATP in mdx
cardiomyocytes is significantly different (* p,0.05) than that induced
by ATP dialysis or DNP treatment.
doi:10.1371/journal.pone.0027034.g003
Altered KATP Function in mdx Cardiomyocytes
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e27034complex in the mdx dystrophic mouse model. The KATP channels
are highly expressed in cardiac tissue, as well as in other
metabolically active tissues, where they are believed to be
responsible for the fine metabolic modulation of membrane
potential-dependent cellular functions [30]. Interestingly, we found
that dystrophic mdx hearts have a significant reduction in PC levels
in normoxic conditions and are more susceptible to hypoxia than
controls. It has been reported that normal KATP channel function is
cardioprotective during an ischemic insult and it relies on the
activity of PC and its enzyme CKm. Moreover, a mutation in the
gene encoding the SUR2A subunit disrupting the catalytic KATP
channel gatinghasbeen linkedto dilated cardiomyopathy inhuman
[31]. Thus, we focused on the analysis of the KATPchannel complex
function and its regulatory enzymes to gain insight into the
pathogenesis of the cardiomyopathy caused by the mdx mutation.
We found that the mdx cardiomyocytes are unable to sense
changes in their metabolic state. In addition, we show that specific
KATP channel complex subunits and CKm, an enzyme essential
for the ATP sensing capabilities of KATP, co-immunoprecipitate
with dystrophin. Importantly, the membrane location of CKm is
lost in mdx cardiomyocytes.
We used three different strategies to reduce the intracellular
ATP concentration in order to open the KATP channel. In wild
type cardiomyocytes all strategies were successful and produced
comparable current values, confirming the presence of functional
channels and their ability to sense variations in ATP levels. In the
perforated patch clamp configuration there is no dialysis of the
intracellular content with the pipette solution and therefore the
intracellular enzymatic milieu remains unaltered. With the
perforated configuration, DNP-induced chemical ischemia in
normal cardiomyocytes caused the insurgence of a potent current
that we characterized as KATP-derived current. In fact, this
current could be blocked by the specific KATP channel blocker
glibenclamide, and an identical current could be induced by the
Figure 4. Current recorded from adult cardiomyocytes. A) Wt and mdx traces primed with 100 mM Pinacidil, before and after application of
DNP 100 mM in voltage clamp whole cell configuration. The voltage protocol used to elicit the current is also indicated. The red trace shows the
current after 5 minutes of DNP application. B) Time course of a recording from wt and mdx cells in relation to the timing of Pinacidil and DNP
application. C) KATP current quantified from the recording of 9 wt (from 3 mice) and 12 mdx (from 4 mice) cells. The current was normalized to the cell
size.
doi:10.1371/journal.pone.0027034.g004
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current was hyperpolarizing and reversed at about 280 mV
strongly suggesting that it was driven by potassium ions.
Surprisingly, mdx cardiomyocytes recorded in identical conditions
did not develop this current upon DNP treatment. These results
were further confirmed by recording the mdx cardiomyocytes in
whole cell configuration. Strikingly, the KATP current that quickly
Figure 5. Kir6.2 retains the t-tubule subcellular localization in the absence of dystrophin. Immuno-fluorescence analysis of young adult
wt and mdx mutant cardiomyocytes stained for Dys427 and Kir6.2 (A, B). Note dystrophin (red) presence at the plasma membrane and t-tubules of
the wt fiber (A, left image) while it is not detectable in the mdx mutant fiber (B, left image). Kir6.2 (green, A and B center images) is associated to the t-
tubules in both wt and mdx mutant fibers. A and B, right images, show co-staining of Dys427 and Kir6.2. Longitudinal optical density profiles (C)
plotted in red for dystrophin and in green for Kir6.2 show identical spacing in wt cardiomyocytes suggesting co-localization of the two proteins. Note
that the profile for Kir6.2 in the mdx mutant fiber is indistinguishable from that of the wt fiber.
doi:10.1371/journal.pone.0027034.g005
Figure 6. Kir6.2 and CKm co-immunoprecipitate with Dys427.
A) Cardiac lysates from wt and mdx animals were immunoprecipitated
with an anti Dys427 antibody and probed for the presence of Kir6.2
(lower part). The membrane was then re-probed with the anti Dys427
antibody (upper part). Kir6.2 is abundant in the total lysate of both wt
and mdx hearts but co-immunoprecipitates with Dys427 only in the wt
sample. B) CKm interacts with dystrophin. Samples as in A were probed
with an anti CKm antibody (lower panel) The membrane was
subsequently reprobed with an anti Dys427 antibody (upper part).
Note that CKm is abundant in the total lysate of both wt and mdx
hearts but co-immuno precipitate with Dys427 only in the wt sample.
doi:10.1371/journal.pone.0027034.g006
Figure 7. CKm and Dys427 are immunoprecipitated by Kir6.2
and SUR2A. Lysates from wt and mdx mouse hearts were
immunoprecipitated with an anti Kir6.2 (A) or SUR2A (B) antibody.
Blots were probed with anti CKm, Dys427, Kir6.2 and SUR2A antibodies.
Inputs (right panels) show that CKm is present in both wt and mdx
lysates but is co-immunoprecipitated by Kir6.2 or SUR2A only in wt
lysates where Dys427 is present.
doi:10.1371/journal.pone.0027034.g007
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level was never observed in the mdx mutant cells. However, in the
mdx cells the current could be recorded in response to the
treatment with cromakalim, a specific agonist of the SUR2A
component of KATP [32]. This is important because it provides
evidence that the KATP multi-octameric complex is both expressed
and assembled at the membrane in mdx cardiomyocytes. It also
suggests that the KATP channel does not open in response to a
decrease in the intracellular concentration of ATP.
The interaction between Kir6.2 and dystrophin is further
confirmed by the immunostaining of adult cardiomyocytes for
dystrophin and Kir6.2. The normal localization of Kir6.2 in wt
cardiomyocytes has been described to be associated with the t-
tubule and excluded from the muscle fiber membrane where
Kir6.1 channels are present instead (25). We also found Kir6.2 in
t-tubules of wt cardiomyocytes. But most importantly, we found
that dystrophin and Kir6.2 share the same location on the t-
tubule. Moreover, lack of dystrophin does not affect Kir6.2
localization at the t-tubules.
It is not yet clear how the KATP channels sense changes in the
metabolic conditions of the cell. The intracellular ATP/ADP ratio
appears to be the most important factor regulating sarcolemmal
KATP channels, whereas ATP and ADP act, respectively as
endogenous blockers and openers of the channels (reviewed by
[33]). In this regard, it has been suggested that there is a close
functional relationship between the adenylate kinase and CKm
phospho transfer, defining the directionality of nucleotide
exchange within the sarcolemmal KATP-channel vicinity [19]. It
has also been shown that CKm is physically associated with the
sarcolemmal KATP channels [14]; genetic disruption of the CKm
gene alters the responses of KATP to metabolic alteration [34] and
pharmacological inhibition of CKm reduces the effect of
mitochondrial uncoupling on KATP channel activity [35], thus
reinforcing the concept that KATP requires CKm for correct
functioning.
Our co-immunoprecipitation results and the loss of CKm from
the mdx membrane fraction suggest that dystrophin may act as a
scaffold creating a protein complex where the KATP and all the
accessory proteins may interact and allow a coordinate sensing of
the cellular metabolic status (Fig. 9). Moreover, the uncoupling of
the KATP channel from cellular metabolic signals has been shown
in another model of cardiac failure. As we found in the mdx heart,
the intrinsic biophysical properties of the KATP channel were
unaltered and the functional deficits of the channel were caused
from cellular remodeling [36].
The lack of dystrophin has considerably different effects in the
cardiac and skeletal muscle. The skeletal muscle is affected soon
after birth with continuous cycles of degeneration/regeneration
and clear signs of cell damage, while cardiac muscle does not show
any cell damage until late adulthood and dilated cardiomyopathy
become evident at a very old age [37]. Even then this damage is
relatively modest and the main histopathological sign is the
gradual accumulation of fibrosis. Despite the lack of obvious
histological abnormalities in young mdx mice, alterations in
metabolic and electrophysiological properties have been reported
[7,8]. Moreover, the mdx-related cardiomyopathy becomes more
pronounced and appears earlier in animals subjected to sustained
physical activity [13]. Interestingly, the mdx
5cv mutant mouse,
despite a much worse skeletal muscle phenotype, shows reduced
cardiac abnormalities when compared to the original mdx mutant
animal. This is probably a reflection of the reduced cardiac
workload associated with the diminished physical activity caused
by the more severe skeletal muscle phenotype in the mdx
5cv
mutant [38]. Further studies have shown that injury to dystrophin-
deficient hearts was significantly correlated with the cardiac
workload since reduction of the workload after the initial physical
stress improved contractility and prevented injury in the mdx
hearts in an ex vivo paradigm [39]. Collectively, all these data
suggest that the dystrophic hearts are capable of sustaining a
moderate workload but they fail when higher performance is
Figure 8. Dystrophin is required for the membrane cellular
localization of CKm. mdx and wt whole heart crude lysates were
fractionated into the membrane (mem) and cytosolic fraction (cyt) and
analyzed by western analysis with antibodies specific for dystrophin
(top panel), BK (middle panel) and CKm (bottom panel). Note the
presence of CKm in the membrane fraction of only the wt lysate while
BK, which was used as a control, is present in both the wt and the mdx
samples. The partial degradation for Dys427 is due to the extraction
without detergent, required for the membrane separation. Multiple BK
bands are due to different glycosylation state of the protein during
synthesis.
doi:10.1371/journal.pone.0027034.g008
Figure 9. Model of how dystrophin could affect KATP channel
function.
doi:10.1371/journal.pone.0027034.g009
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mutant heart is more susceptible to stress. Our data support the
hypothesis that dystrophin functions as a scaffolding protein that
correctly assembles the enzymes required by the KATP channel for
sensing the metabolic state of the cell and protecting it from
physical stress or ischemia (Fig. 9). This mechanism is further
supported by the demonstration that functional KATP channels are
cardioprotective since they are required for adaptation to stress
[22]. Any impairment in their physiological function, such as the
defects that we have reported in the mdx heart may contribute to
the development of cardiomyopathy. This finding is important
because it furthers our understanding into the molecular deficits
caused by a lack of dystrophin and, if confirmed in human, may
provide the basis for the development of new strategies for the
pharmacological treatment of DMD cardiomyopathy.
Materials and Methods
Animal
Wild type (C57BL/10 ScSn, wt) and genetically dystrophic
(C57BL/10 mdx) male mice (Jackson Laboratory) were used for all
experiments. Animals were treated in accordance with the
guidelines provided by the Animal Care and Use Committee of
the National Cancer Institute at Frederick, Maryland and in
accordance with guidelines established by the Italian Council for
animal care. A total of 8 animals per group (2–3 months old males
for the young adult and 12-13 months old for the old adult group)
were used for the electrophysiology, 3 animals per group were used
for RT-PCR (2–3 month old males; see Methods S1; primer used in
table S1) and western blot analysis and 5 animals per group for
biochemistry (10–12 months old). Embryos at embryonic day 17.5
(E17.5) were used for deriving embryonic cardiomyocytes.
Heart isolation and perfusion
Mice were heparinized (500 IU/kg i.p.) 15 minutes prior to the
surgical heart explantation and then anesthetized with 50 mg/kg
i.p. sodium pentobarbital. The hearts were rapidly excised and
perfused using a standard Langendorff method at a constant
pressure of 55 mmHg with KHS (118 mM NaCl, 4.7 mM KCl,
2.2 mM CaCl2, 1.2 mM MgSO4, 0.5 mM EDTA, 25 mM
NaHCO3, 11 mM glucose, pH 7.3; all reagents are from Sigma).
Heart rate and left ventricular pressure were checked using a latex
balloon, placed into the left ventricle and connected to a pressure
transducer. Only hearts with a heart rate higher than 300 bpm
after 30 min of perfusion were used for NMR (see Supporting
Information Methods S1) and biochemical analysis (normoxic
condition). Hearts were subjected to global hypoxia by switching
to a 95% N2,5 %C O 2 saturated perfusion medium for a period of
10 min and used for biochemical analysis.
Biochemical analysis
High-energy phosphate compounds, creatine and inorganic
phosphate (Pi) were estimated by HPLC methods as previously
described [40]. Briefly, after perfusion, normoxic and hypoxic hearts
were quickly frozen in chilled isopentane and freeze-dried for at least
20 hours. Samples were powdered with a mechanical homogenizer
(Mixer Mill, MM200). The dried tissue powder was dissolved in
0.42 M perchloric acid and, after neutralization and precipitation by
1 M KOH, the extract was injected into the HPLC system.
Cellular protein sub-fraction and Western blotting
analysis
Animals were euthanized in a CO2 chamber and the heart
quickly removed. The ventricular wall was homogenized in ice-
cold buffer I (TRIS 10 mM, NaH2PO4 20 mM, EDTA 1 mM,
protease inhibitor cocktail (Roche) pH 7.8) and centrifuged at
5000 g 610 min. The supernatant was ultra-centrifuged at
35000 g; the pellet containing the membrane fraction was
dissolved in buffer II (HEPES 20 mM, NaCl 150 mM, Triton
X100 1%, pH 7.5). Total protein concentration was determined
using the Bradford method. The cytosolic and membrane fractions
were separated on 4%–12% Tris-Glycine Gels (Invitrogen) and
electroblotted onto a polyvinylidene difluoride membrane (In-
vitrolon). The membrane was divided in three strips by cutting at
approximately 110 and 60 KDa. The upper part was used to
detect the full length dystrophin (Dys427) with anti-DYS1
antibody (Novocastra Labs), the middle part was used as a control
of the cell membrane fraction by hybridizing with an antibody
specific to the calcium modulated potassium channel BK (APC-
021, Alomone Labs) and the lower part for detection of the CKm
(sc-15164, Santa Cruz Biotech). The membrane strips were
incubated with the specific primary antibody overnight at 4uC.
Appropriate peroxidase conjugated secondary antibody was
applied for 1 hour at RT and detected with chemiluminescent
reagent (GE HealthCare). The strips were recomposed in the
original position and X ray films were exposed and digitized for
further data analysis.
Immunoprecipitation
The ventricular wall was homogenized in ice cold buffer II (GE
Healthcare). Pre-clearing was done with goat or rabbit serum
(10 ml/ml) and 10 ml of protein A/G PLUS-Agarose (sc-2003) for
one hour at 4uC and centrifuged for 10 min at 13500 rpm at 4uC.
The supernatant was incubated with an anti-DYS1 (Novocastra
Labs; 1/100), an anti Kir6.2 or anti SUR2A (sc-20809, sc-25684
Santa Cruz Biotech 1/200) antibody overnight at 4uC. The
resulting immuno complex was precipitated with protein A/G
PLUS-Agarose for 3 hours at 4uC. Beads were washed with buffer
II (56500 ml) using micro columns (GE Healthcare), re-suspended
in Laemmli sample buffer, boiled for 3 min and the proteins
recovered by centrifugation at 13500 rpm 62 min were analyzed
by western blotting as described above with the CKm, Kir6.2 (ab-
79582, AbCam 1/1000), SUR2A (sc-32462 Santa Cruz Biotech
1/200) or Dys427 antibodies.
Electrophysiology
Mouse embryonic cardiomyocytes were cultured from wt and
mdx mice and used for electrophysiological measurements after 4
days in vitro. Briefly, embryonic hearts were isolated and cultured
by successive digestion with 0.25% trypsin (Gibco) and 0.2%
collagenase type II (Sigma). Fibroblast contamination was
minimized by pre-plating cells onto tissue culture dishes for 60
minutes. The cardiomyocyte enriched cultures were plated onto
laminin-coated (Invitrogen) 1 cm glass coverslips placed on a 6 cm
culture dish at a density of 2610
4 cells per cm
2. Growth medium
consisted of 25 mM glucose DMEM lacking L-glutamine (Gibco)
supplemented with 10% fetal bovine serum (Hyclone) and 1%
gentamycin, 1% penicillin/streptomycin, and 1% antimycotic. A
single coverslip was transferred into the recording chamber and
perfused with Tyrode solution (in mM: NaCl 136.5, KCl 5.4,
CaCl2 1.8, MgCl2 0.53, glucose 5.5, HEPES2NaOH 5.5;
pH 7.4). Perforated patch clamp was obtained with borosilicate
glass pipette filled with (in mM): KCl 140, MgCl2 1, HEPES2
KOH 5 (pH 7.3) and Nystatin dissolved in DMSO (0.1 mg/ml) at
a final concentation of approximately 400 mg/ml. A ramp from -
120 mV to 40 mV in 1 sec was applied every 20 second from a
holding potential of 240 mV. IATP was elicited by different
methods: by poisoning of mitochondria with dinitrophenol (DNP;
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potassium current [41] within 10 to 20 minutes; with the specific
agonist Cromakalim 100 mM, and by dialysis of ATP in whole cell
configuration with no ATP in the recording pipette (intracellular
as in perforated but without nystatin). Glibenclamide 25 mM
(Sigma) and Cromakalim 100 mM (Sigma) were used respectively
as antagonist and agonist of IATP. Membrane capacitance, which
is directly related to cell size, was calculated for each cell by
measuring the area under the transient capacitive currents elicited
by 5 mV depolarizing pulses from 240 mV and acquired at a
sampling rate of 50 kHz, after subtraction of the steady-state
current component. Cell capacitance was used to normalize the
current values to the cell size such that the values are expressed as
pico Ampere/pico Farad (pA/pF).
Dissociation and electrophysiological recording of adult
cardiomyocytes
Mice were heparinized (500 IU/kg i.p.) 15 minutes prior to the
removal of the heart. The hearts were rapidly excised (from mice
anesthetized with Fluotane) and perfused using a standard
Langendorff method at a constant pressure of 55 mmHg with
‘‘Isolation buffer’’ (130 mM NaCl, 5.4 mM KCl, 0.5 mM MgCl2,
25 mM HEPES, 0.33 mM NaH2PO4, 22 mM D-glucose, 1 mM
Lactic acid, 3 mM Pyruvic acid, 5 U insulin, 0.1 mM EGTA
pH 7.4; all reagents are from Sigma). After 3–5 min of washing
the solution was changed to the ‘‘digestion solution’’ (Isolation
solution without EGTA with added 50 mM CaCl2, and
Collagenase Type II 300 U/ml Worthington Lakewood NJ).
Digestion was performed for 5–8 min and then the heart was
minced in Isolation buffer plus 250 mM CaCl2, without EGTA.
The dissociated cardiomyocytes were centrifuged at 100 g for 5
minutes and resuspended in DMEM at room temperature.
Cardiomyocytes transferred to the recording chamber were
perfused with 130 mM NaCl, 5.4 mM KCl, 0.5 mM MgCl2,
1 mM CaCl2, 5.5 mM HEPES, 5 mM D-glucose. Rod shaped
adult cardiomyocytes were recorded in whole cell configuration as
described in [5]. The pipette solution was: 55 mM KCl, 85 mM
K-Gluconate, 1 mM MgCl2, 10 mM HEPES, 100 mM EGTA,
pH 7.4 and maintained at a holding potential of 240 mV. DNP
and Pinacidil were dissolved in DMSO as stock and dissolved to
the final concentration in the perfusion solution just before their
use. Ramp voltage protocol (120 mV/s) was applied every 20 s.
The KATP current was evaluated at +40 mV. Glibenclamide
(25 mM) completely inhibited the current and was used to
pharmacologically characterize the current. Pinacidil (100 mM)
was used to prime the KATP channel such that the subsequent
application of DNP 100 mM allowed the channel to open [35].
Immunostaining of adult cardiomyocytes
Adult cardiomyocytes were dissociated as described above,
plated on laminin coated coverslips, fixed with 3.5% paraformal-
dehyde in PBS for 10 minutes at room temperature and placed in
ice cold methanol for 5 minutes on ice. Cardiomyocytes were then
rinsed (365 min) in PBS and blocked with 5% donkey serum in
PBS and 0.1% triton X100 for one hour at RT. Cells were then
washed (365 min) with wash buffer (PBS with 0.5% donkey serum
and 0.01% triton X100). The primary antibody incubation was
performed for one hour at RT in wash buffer. Anti Dys-427 (NCL-
DYS1, Novocastra 1/1000) and anti Kir6.2 (APC-020, Alomone
labs 1/1000) were used to detect the full-length dystrophin and
Kir6.2 subunit, respectively. Alexa Fluor 568 donkey anti mouse
antibody (1/2500) was used to detect dystrophin; Alexa Fluor 647
donkey anti rabbit was used to detect Kir6.2 (1/2500). The
secondary antibody incubation was performed for 30 min at RT
in wash buffer. Coverslips were then washed (365 min) and
mounted for confocal microscopy analysis (Zeiss LSM-510).
Optical density profiles were integrated from a 100 pixel height
box in the appropriate axis with image-J and plotted in excel
(Microsoft).
Statistical analysis
Data (mean6SE) were compared by the Student’s T test or by
the one way ANOVA test where appropriate. P,0.05 was
considered statistically significant.
Supporting Information
Figure S1
31P NMR spectra. Averages of 4 traces from a
control mouse heart (continuous line) and from an mdx mouse
heart (dotted line) are shown. Note the increase in the peak area of
Pi and the decrease in the peak area of PC in the mdx trace.
(TIF)
Figure S2 Current recorded from an mdx neonatal
cardiomyocyte in voltage clamp whole cell configura-
tion. The voltage protocol used to elicit the current is also shown.
The red trace shows the current after 10 minutes from the break
in, and the black trace the current obtained 5 minutes after
perfusion with 100 mM of Cromakalim. The red trace shows a fast
outward spike of current that arises when the applied ramp
reached approximately -50 mV. This current is likely due to the
opening of a mixture of calcium and sodium voltage gated
channels and is shunted in the black trace by the IATP. The
recording conditions are: intracellular solution (in mM): KCl 140,
MgCl2 1, HEPES2KOH 5, pH 7.3. Perfusion solution (in mM):
NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glucose 5.5,
HEPES2NaOH 5.5; pH 7.4.
(TIF)
Figure S3 Kir6.2 and a-Syntrophin but not Rho-GDI co-
immunoprecipitate with Dys427. Heart lysates from wt and
mdx animals were immunoprecipitated with an anti Dys427
antibody and analyzed by Western analysis. Membranes were cut
horizontally using the molecular markers as reference and probed
with an anti- Kir6.2, a -Syntrophin, Rho-GDI and anti Dys427
antibody. Note, that dystrophin is detected as expected in the wt
but not in the mdx mutant hearts whereas Kir6.2 and a -
Syntrophin (used as positive controls for the IP) are present in the
total lysate (inputs) of both wt and mdx heart but co-immuno
precipitate with Dys427 only in the wt sample. RhoGDI (used as
negative control for the IP) is present in the inputs but does not co-
IP with dystrophin.
(TIF)
Figure S4 The mRNA level for the SUR2A, SUR2B,
SUR1, Kir6.1, Kir6.2 and CKm genes is unaltered in the
mdx hearts compared to wt controls. Real time PCR
amplification of cDNA obtained from reverse transcription of
mRNA extracted from wt and mdx heart. Note the lack of
significant differences in expression of any of the tested genes
between genotypes.
(TIF)
Table S1 Primers used for real time PCR.
(DOC)
Table S2 I-KATP induced by the application of agonist
(cromakalim 100 mM) and measured at +40 mV. Values
(average and SE are expressed as pA/pF).
(DOC)
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